A Rare Case of Posterior Mediastinal Seminoma Mimicking Primary Lung Neoplasm


Abstract / PDF

A Rare Case of Posterior Mediastinal Seminoma Mimicking Primary Lung Neoplasm

Sian Yik Lim MDa, Grerk Sutamtewagul MDa, Ragesh Panikkath MDa, Fred Hardwicke MDb

Correspondence to Sian Yik Lim MD.

  Email: sianyik.lim@ttuhsc.edu




 + Author Affiliation
 - Author Affiliation

  a residents in Internal Medicine at Texas Tech University Health Science Center in Lubbock, TX

  b an oncologist in the Department of Internal Medicine at TTUHSC in Lubbock, TX

 




SWRCCC : 2013;1.(2):39-42

doi: 10.12746/swrccc2013.0102.023

...................................................................................................................................................................................................................................................................................................................................
Abstract

We report an atypical case of posterior  mediastinal seminoma. Mediastinal seminomas are a rare form of tumor usually  located in the anterior mediastinum. Our case presented as a diagnostic  challenge because of the difficulty of differentiating the primary mediastinal  mass from a primary lung neoplasm. Our case highlights the fact that seminomas  may occur in the posterior mediastinum and the importance of considering a  broad differential diagnosis, especially in cases of poorly differentiated  carcinoma of the mediastinum.



Keywords : primary  mediastinal seminoma, posterior mediastinum, primary lung neoplasm,  immunohistochemical staining, tissue biopsy

...................................................................................................................................................................................................................................................................................................................................

Introduction



Mediastinal  seminomas are a rare form of tumor, accounting for three to four percent of  mediastinal masses.1 Their usual location is  in the anterior mediastinum. We report an atypical case of primary mediastinal  seminoma occurring in the posterior mediastinum in a 51-year-old man. Posterior  mediastinum seminomas areextremely rare with only a few cases previously  reported.2,3 Our case is  interesting because it was difficult to differentiate the posterior mediastinal  mass from a primary lung tumor due to extension of the mass into the upper and  lower lobes of the lung. This feature has not been mentioned in the other case  reports. In cases of undifferentiated carcinoma of the mediastinum, additional  evaluation of tissue biopsy using immunohistochemical stains is important.



Case Presentation

Our patient is a 51-year-old previously healthy  man with significant smoking history (50 pack years) who presented to our  hospital with a chief complaint of a three week history of hemoptysis. He began  to notice a productive cough with greenish sputum three months prior to  presentation. This was associated with bilateral posterior pleuritic chest pain  and a 40 pound weight loss over two months. His cough progressively worsened, and  he began to develop hemoptysis. He was initially treated with a 10 day course  of doxycycline with no improvement of his symptoms. A chest X-ray (Figure 1)  showed a mass in the right lung which led to referral to our hospital. On  presentation, he had right sided wheezes on physical exam. Computed tomography  (CT) scan of the chestshowed an irregular poorly enhancing mass in the right  perihilar region extending into the right upper and lower lobes with encasement  of the right bronchus intermedius (Figure 2).An ultrasound-guided  transbronchial needle biopsy of the mass revealed a poorly differentiated tumor  consisting of large cells with vesicular irregular nuclei and abundant  necrosis. Additional staining showed an immunophenotype positive for  cytokeratin (AE/AE3) and placental alkaline phosphatase and negative for CK6,  CK20, TTF1, p63, and CD30. This pattern was consistent with the pathological  diagnosis of seminoma. Scrotal ultrasound did not demonstrate any mass present.  The tumor markers beta human chorionic gonadotropin (beta-HCG), lactate  dehydrogenase, and alpha fetoprotein (AFP) were negative. Physical exam and CT  scans of the head, abdomen, and pelvis did not reveal other foci of metastasis.  He was diagnosed with primary mediastinal seminoma and was started on  bleomycin, etoposide, and cisplatin. His symptoms improved significantly after his  first cycle of chemotherapy, and he remains on treatment.





Figure 1: Chest  X-ray on admission, showing a mass in the right lung.





Figure 2 CT  scan showing a right mass extending from right perihilar region. 




Discussion

Germ cell tumors are classified as extragonadal  if there is no evidence of a primary tumor in the gonads. Extragonadal germ  cell tumors typically arise in midline locations, and in adults the most common  sites are the anterior mediastinum, retroperitoneum, pineal, and suprasellar  regions. Posterior mediastinal seminoma is a rare occurrencewith only a few  cases reported in the literature.2,3 Our case was atypical because the tumor  extended into the lung, and this led to an initial impression of aprimary lung  neoplasm.

The gonad emerges on the ventromedial surface  of the mesonephros at the fourth week of gestation. Primordial germ cells  migrate from the wall of the yolk sac along the dorsal mesentery of the hind  gut to the gonadal ridges. Classically, it is thought that extragonadal germ  cell tumors arise from primordial germ cells ‘misplaced’ due to aberrant  migration during embryogenesis. However, this hypothesis has been challenged,  and reverse migration of carcinoma in situ lesions in the testis has been  suggested as an alternative hypothesis.4

Primary mediastinal seminomas cause one-third  of malignant mediastinal germ cell tumors and occur predominantly in men age 20  to 40 year of age.The morphologic features of primary mediastinal seminoma are  similar to those tumors occurring in the gonads.5 As in gonadal germ cell tumors, they occur  more commonly in young adults, have i (12p) karyotypic abnormalities, and are sensitive  to carboplatin based chemotherapy regimens. About 20%-30% of patients are  asymptomatic at the time of presentation.6 When symptoms are present, they relate to the  size and location of the tumorwhich can compress and/or invade mediastinal structures.  The most common presenting symptoms of mediastinal seminoma include chest pain  (39%), dyspnea (29%), cough (22%), and weight loss(19%).7

Mediastinal seminomas appear as large,  unencapsulated, well-circumscribed masses. On CT scans, seminomas appear large  and coarsely lobulated and typically have homogeneous attenuation equal to that  of soft tissue. Calcification is usually absent. These masses can compress  mediastinal structures.8 As is the case with extragonadal  nonseminomatous germ cell tumors, extragonadal seminomas may present as  histologically poorly differentiated carcinomaand should be considered in the  differential diagnosis of poorly differentiated cancer.2 The diagnosis of mediastinal germ cell tumors  can be established with a high degree of accuracy through fine needle  aspiration biopsy with immunohistochemical analysis.9  After the diagnosis of a germ cell tumor is made, a primary testicular tumor  must be excluded, and ultrasonography should be performed in all patients since   testicular palpation is insufficient to  exclude a primary testicular tumor.10 Patients with extragonadal seminomas may have  small increases in beta-HCG levels. The presence of AFP excludes the diagnosis  of a pure seminoma.10

Primary mediastinal seminomas are exquisitely  sensitive to both cisplatin-based chemotherapy and radiation therapy. Patients  such as ours who do not have evidence of nonpulmonary visceral metastases have  good prognoses, and these tumors are classified as good risk germ cell tumors  by the International Germ Cell Consensus Classification.11 Most centers prefer chemotherapy to radiation  therapy for patients with primary mediastinal seminoma because of the concern  about increased risk of cardiovascular events following mediastinal radiation  therapy. Although no randomized controlled trials have been performed, initial  chemotherapy was associated with better long-term disease-free survival.1,12 There is usually no role for  surgical resection/debulking in the initial management of primary mediastinal  seminoma. Residual masses post-chemotherapy less than three cm in size are managed  with routine surveillance. If the residual mass is more than three cm,  management is controversial since 30% of these patients have residual tumor.  Treatment options includesurveillance, additional evaluation with positron  emission tomography (PET) scans, or surgical resection.

In  summary, this atypical case of posterior mediastinal seminoma highlights the  importance of considering these rare tumors in the differential diagnosis of  poorly differentiated carcinoma of the mediastinum. Although typically  presenting as an anterior mediastinal mass, primary mediastinal seminoma may  present in the posterior mediastinum and may be difficult to differentiate from  a lung mass. Ordering appropriate tests is important and should lead to an  accurate diagnosis and appropriate management.





Key Points



	 Although  usually presenting as an anterior mediastinal mass, primary mediastinal  seminomas may present as a mass in the posterior mediastinum.
	 Primary  mediastinal seminomas need to be considered in the differential diagnosis of  poorly differentiated carcinoma of the mediastinum. The diagnosis can be  established by the ordering additional immunohistochemical staining.






References

	 Jain KK, Bosl GJ, Bains MS,  Whitmore WF, Golbey RB. The treatment of extragonadal seminoma. Journal of  clinical oncology : official journal of the American Society of Clinical  Oncology 1984;2:820-7.
	 Ravenel JG, Gordon LL, Block MI, Chaudhary  U. Primary posterior mediastinal seminoma. AJR American journal of  roentgenology 2004;183:1835-7.
	 Makiyama K, Senga Y. Primary  seminoma in the posterior mediastinum. The Journal of urology 2001;165:908.
	 Chaganti RS, Houldsworth J. The  cytogenetic theory of the pathogenesis of human adult male germ cell tumors.  Review article. APMIS : acta pathologica, microbiologica, et immunologica  Scandinavica 1998;106:80-3; discussion 3-4.
	 Moran CA, Suster S, Przygodzki RM,  Koss MN. Primary germ cell tumors of the mediastinum: II. Mediastinal  seminomas--a clinicopathologic and immunohistochemical study of 120 cases.  Cancer 1997;80:691-8.
	 Aygun C, Slawson RG, Bajaj K,  Salazar OM. Primary mediastinal seminoma. Urology 1984;23:109-17.
	 Bokemeyer C, Droz JP, Horwich A,  et al. Extragonadal seminoma: an international multicenter analysis of  prognostic factors and long term treatment outcome. Cancer 2001;91:1394-401.
	 Rosado-de-Christenson ML,  Templeton PA, Moran CA. From the archives of the AFIP. Mediastinal germ cell  tumors: radiologic and pathologic correlation. Radiographics : a review  publication of the Radiological Society of  North America, Inc 1992;12:1013-30.
	 Chhieng DC, Lin O, Moran CA, et  al. Fine-needle aspiration biopsy of nonteratomatous germ cell tumors of the  mediastinum. American journal of clinical pathology 2002;118:418-24.
	 Gilligan TD, Kantoff PW.  Extragonadal germ cell tumors involving the mediastinum and  retroperitoneumWaltham, MA: UpToDate; 2013. 
	 International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15:594-603.
	 Fizazi K, Culine S, Droz JP, et al. Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy? Eur J Cancer 1998;34:347-52.


...................................................................................................................................................................................................................................................................................................................................




Received:  03/13/2013

Accepted:  03/21/2013

Reviewers:  Aliakbar Arvandi MD, Kenneth Nugent MD

Published electronically: 04/15/2013

Conflict of Interest Disclosures: none



 

Return to top